EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Disseminated hepatic epithelioid hemangioendothelioma with multiorgan metastases achieving long-term stability with Pazopanib: a case report

Alaa Naiem Zaro, Salar Nael Sajadieh, Ansam Khaled Doudin, Salem K Qupp, Laith Elayan, Ola Abu Laban, Marwan Qabaja, Amaal Alamleh

Frontiers in Oncology · 03.06.2026 · 16

DOI: 10.3389/fonc.2026.1834539 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 03.06.2026. Verfasst von Alaa Naiem Zaro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Al-Quds University, Jerusalem, Palestine. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives Epithelioid Hemangioendothelioma (EHE) is a rare malignant vascular neoplasm with an unpredictable clinical behavior and often delayed diagnosis. The malignancy arises from many anatomical sites, with the liver being the most common primary site. This report portrays a young patient who presented atypically with a multifocal hepatic epithelioid hemangioendothelioma (HEHE) and highlights the challenges faced during the diagnosis and management of such rare malignancies.

Methods

A 28-year-old male patient from Palestine presented with progressive headache associated with constitutional symptoms. Diagnostic imaging revealed disseminated disease throughout the body. CT-guided liver biopsy confirmed neoplastic cells arranged in small nests and individually, some of which showed intracytoplasmic vacuoles within a hyalinized stroma. Immunohistochemistry was positive for CD31, CD34 and FLI-1, supporting the endothelial origin. Metastatic HEHE was established; a biological treatment plan with Pazopanib (Votrient) was initiated, and the patient was followed for 4 years.

Results

During the follow-up period, serial imaging revealed no significant regression or progression of the lesions, indicating stable disease with the treatment used.

Conclusion

The case emphasizes the clinical intricacy of HEHE, given its rarity, the lack of standardized treatment guidelines, and the tumor’s unpredictable course. Specifically, this case illustrates these challenges within the Palestinian healthcare system.

Schlagwörter

Stichwörter der Autor:innen

Pazopanibcase reporthepatic epithelioid hemangioendotheliomaimmunohistochemistrymetastasis

Autor:innen und Institutionen

  • Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
  • Department of Oncology, Augusta Victoria Hospital, Jerusalem, Palestine.

Zitieren

APA

Zaro, A. N., Sajadieh, S. N., Doudin, A. K., Qupp, S. K., Elayan, L., Laban, O. A., Qabaja, M., & Alamleh, A. (2026). Disseminated hepatic epithelioid hemangioendothelioma with multiorgan metastases achieving long-term stability with Pazopanib: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1834539

Vancouver

Zaro AN, Sajadieh SN, Doudin AK, Qupp SK, Elayan L, Laban OA, et al. Disseminated hepatic epithelioid hemangioendothelioma with multiorgan metastases achieving long-term stability with Pazopanib: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1834539

BibTeX
@article{Zaro2026,
  author = {Zaro, Alaa Naiem and Sajadieh, Salar Nael and Doudin, Ansam Khaled and Qupp, Salem K and Elayan, Laith and Laban, Ola Abu and Qabaja, Marwan and Alamleh, Amaal},
  title = {Disseminated hepatic epithelioid hemangioendothelioma with multiorgan metastases achieving long-term stability with Pazopanib: a case report},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1834539}
}
Kostenlos starten →